Liraglutide – sold under the brand names Saxenda and Victoza – is a class of drug known as a glucagon-like peptide-1 (GLP-1) receptor agonist, like semaglutide – commonly known as Ozempic and Wegovy.
Hamlet Gasoyan, Ph.D., Lead Author, Cleveland Clinic Semaglutide (sold under the brand names Wegovy and Ozempic) and liraglutide (sold under the brand names Saxenda and Victoza) are glucagon-like ...
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.
U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...
Jon Gosselin dropped more than 50 lbs after starting semaglutide injections, but once he ran out of the weight-loss shots due ...
Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...
Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's ...
Zmyra has become a standout natural alternative to Ozempic for weight loss. Reviewers for this article believe it to be the ...
Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
A new study suggests that semaglutide, a blockbuster anti-obesity GLP-1 drug, could help people cut down on addictive behavior and prevent opioid overdose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback